BioNTech SE (BNTX) Change in Cash (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Change in Cash data on file, last reported at -$2.8 billion in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash fell 2045.25% year-over-year to -$2.8 billion; the trailing twelve-month figure through Dec 2025 stood at -$2.5 billion (down 16.5% YoY), and the FY2025 full-year result was -$2.3 billion, down 13.77% from the prior year.
• Change in Cash eased to -$2.8 billion in Q4 2025, from -$182.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $5.0 billion in Q1 2022 to a low of -$2.9 billion in Q1 2024.
• A 5-year average of $465.9 million and a median of $111.7 million in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash jumped 75234909.21% in 2022 and slumped 2045.25% in 2025, its largest moves.
• Tracing BNTX's Change in Cash over 5 years: stood at -$818.4 in 2021, then jumped by 75234909.21% to $615.7 million in 2022, then slumped by 424.52% to -$2.0 billion in 2023, then soared by 107.28% to $145.4 million in 2024, then tumbled by 2045.25% to -$2.8 billion in 2025.
• Business Quant data shows BNTX's Change in Cash at -$2.8 billion in Q4 2025, -$182.5 million in Q3 2025, and $77.9 million in Q2 2025.